4-Hydroxy-3-methylbenzonitrile - CAS 15777-70-5
Catalog: |
BB060836 |
Product Name: |
4-Hydroxy-3-methylbenzonitrile |
CAS: |
15777-70-5 |
Synonyms: |
4-hydroxy-3-methylbenzonitrile; 4-hydroxy-3-methyl-benzonitrile; Benzonitrile, 4-hydroxy-3-methyl-; 4-cyanocresol; 4-CYANO-2-METHYLPHENOL; 3-methyl-4-hydroxybenzonitrile; 3-methyl-4-hydroxy-benzonitrile |
IUPAC Name: | 4-hydroxy-3-methylbenzonitrile |
Description: | 4-Hydroxy-3-methylbenzonitrile |
Molecular Weight: | 133.15 |
Molecular Formula: | C8H7NO |
Canonical SMILES: | CC1=C(C=CC(=C1)C#N)O |
InChI: | InChI=1S/C8H7NO/c1-6-4-7(5-9)2-3-8(6)10/h2-4,10H,1H3 |
InChI Key: | WTTADDGUHFYGEH-UHFFFAOYSA-N |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021257544-A1 | Sox11 inhibitors for treating mantle cell lymphoma | 20200616 |
EP-3901152-A1 | Kv3 enhancers for the treatment of cognitive disorders | 20200423 |
US-2021186935-A1 | Rapamycin analogs and uses thereof | 20191205 |
WO-2021058979-A1 | Therapy | 20190925 |
WO-2020009946-A1 | Therapeutic compounds and methods of use thereof | 20180702 |
US-2021269438-A1 | Therapeutic compounds and methods of use thereof | 20180702 |
WO-2019241566-A1 | Amidines and amidine analogs for the treatment of bacterial infections and potentiation antibiotics | 20180614 |
CN-112566631-A | Amidines and amidine analogs for the treatment of bacterial infections and potentiation of antibiotics | 20180614 |
EP-3806836-A1 | Amidines and amidine analogs for the treatment of bacterial infections and potentiation antibiotics | 20180614 |
US-2021309641-A1 | Amidines and amidine analogs for the treatment of bacterial infections and potentiation antibiotics | 20180614 |
Complexity: | 158 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 133.052763847 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 133.052763847 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 44Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS